<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="365101">
  <stage>Registered</stage>
  <submitdate>4/10/2013</submitdate>
  <approvaldate>24/10/2013</approvaldate>
  <actrnumber>ACTRN12613001172796</actrnumber>
  <trial_identification>
    <studytitle>The Fluid Translation of Research into Practice Study (Fluid-TRIPS): An International Cross-Sectional Survey of Fluid Resuscitation Practice in Intensive Care Unit Patients 

</studytitle>
    <scientifictitle>Translating reliable evidence on fluid resuscitation of intensive care patients into clinical practice  Improving patient outcomes and containing public health costs </scientifictitle>
    <utrn>U1111-1148-7823 </utrn>
    <trialacronym>Fluid-TRIPS</trialacronym>
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>fluid resuscitation in intensive care unit</healthcondition>
    <conditioncode>
      <conditioncode1>Public Health</conditioncode1>
      <conditioncode2>Health service research</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>An international cross-sectional survey will be undertaken which audits fluid resuscitation practice in participating ICUs on a single day. </interventions>
    <comparator>No control group</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>To describe the amount and type of resuscitation fluid currently administered to adult patients in intensive care units (ICU) in different countries</outcome>
      <timepoint>Data will be collected over a designated 24-hour study day</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>To describe and compare the costs of fluid choice between different geographical regions</outcome>
      <timepoint>Data will be collected over a designated 24-hour study day</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Adult patients present in the ICU at the 10am census at the start of on the study day or admitted during the 24-hour study period will be included in the study sample.</inclusivecriteria>
    <inclusiveminage>16</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Children under 16 years are excluded</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs>Screening</purposeobs>
    <duration>Cross-sectional</duration>
    <selection>Random sample</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>30/04/2014</anticipatedstartdate>
    <actualstartdate>30/04/2014</actualstartdate>
    <anticipatedenddate>10/12/2014</anticipatedenddate>
    <actualenddate>10/12/2014</actualenddate>
    <samplesize>2100</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up complete</recruitmentstatus>
    <recruitmentcountry>Australia,Outside</recruitmentcountry>
    <recruitmentstate>ACT,NSW,NT,QLD,SA,TAS,WA,VIC</recruitmentstate>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Belgium</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Brazil</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>China</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Denmark</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Finland</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Canada</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Netherlands</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Saudi Arabia</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Sweden</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United Kingdom</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States of America</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Viet Nam</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>India</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Iceland</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>The George Institute for global health</primarysponsorname>
    <primarysponsoraddress>Level 13 321 Kent Street Sydney NSW 2000 Australia</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Other</fundingtype>
      <fundingname>The George Institute for global health; Critical Care &amp; Trauma Division</fundingname>
      <fundingaddress>Level 13 321 Kent Street Sydney NSW 2000 Australia</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>Not applicable</sponsorname>
      <sponsoraddress>Not applicable</sponsoraddress>
      <sponsorcountry />
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Colman Taylor (Co-Principle Investigator)</othercollaboratorname>
      <othercollaboratoraddress>The George Institute for Global Health
Critical Care and Trauma Division

Level 13 321 Kent Street Sydney NSW 2000 </othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The objective of this project is to describe international trends in the prescription of intravenous fluids for fluid resuscitation in intensive care and to determine the major drivers of choice.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Sydney Local Health District Ethics Review Committee (RPAH Zone)</ethicname>
      <ethicaddress>Research Development Office
Suite 210A
RPAH Medical Centre
100 Carillon Avenue
NEWTOWN NSW 2042</ethicaddress>
      <ethicapprovaldate>17/04/2014</ethicapprovaldate>
      <hrec>EC00152</hrec>
      <ethicsubmitdate>16/12/2013</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Ms</title>
      <name>Naomi Hammond </name>
      <address>The George institute for global health
Critical Care and Trauma Division,
Level 13
321 Kent Street
Sydney NSW 2000 Australia</address>
      <phone>61 2 9657 0352</phone>
      <fax />
      <email>nhammond@georgeinstitute.org.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Ms</title>
      <name>Maryam Correa</name>
      <address>The George institute for global health
Critical Care and Trauma Division,
Level 13
321 Kent Street
Sydney NSW 2000</address>
      <phone>61 2 82382467</phone>
      <fax />
      <email>mcorrea@georgeinstitute.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Ms</title>
      <name>Maryam Correa</name>
      <address>The George institute for global health
Critical Care and Trauma Division,
Level 13
321 Kent Street
Sydney NSW 2000</address>
      <phone>61 2 82382467</phone>
      <fax />
      <email>mcorrea@georgeinstitute.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Ms</title>
      <name>Maryam Correa</name>
      <address>The George institute for global health
Critical Care and Trauma Division,
Level 13
321 Kent Street
Sydney NSW 2000</address>
      <phone />
      <fax />
      <email>mcorrea@georgeinstitute.org.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>